Other Content - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Other Content
Equipment and processing in pharma, biopharma, specialty & generic drug manufacturing. Aseptic processing, cytotoxic manufacturing, small & large molecules.

Understanding the Cleaning Validation Lifecycle

April 16, 2014

Equipment and Processing Report

The cleaning validation lifecycle includes assessment, development, validation, and monitoring.

Advances in Continuous Biopharmaceutical Manufacturing

April 16, 2014

Equipment and Processing Report

Both upstream and downstream processes can benefit from continuous manufacturing advantages.

European Union Regulation Reforms Affect Cold-Chain Management

April 16, 2014
Equipment and Processing Report

Tony Wright, CEO of Exelsius Cold Chain Management, answers questions about the new requirements for temperature-controlled pharmaceutical distribution.

Increased Efficiency Key to Competitiveness in Downstream Bioprocessing

April 2, 2014

Pharmaceutical Technology

Higher antibody titers and a growing demand for smaller-volume, flexible processes are creating the need for more cost-effective downstream processing.

Appropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs

April 2, 2014

Pharmaceutical Technology

Increasing potency and growing interest in antibody-drug conjugates are creating challenges for manufacturers of HPAPIs.

Evaluating the Sterile Barrier of Complex Drug Delivery Systems

April 2, 2014

Pharmaceutical Technology

Methods of validating and assuring container closure integrity are crucial for quality assurance.

Continuous Manufacturing Discussions at the INTERPHEX Innovation Stage

March 17, 2014

Equipment and Processing Report

Experts will examine continuous processing in solid-dosage and biopharmaceutical production.

Defining the Sterile Barrier of Complex Drug Delivery Systems

March 17, 2014

Equipment and Processing Report

New injection-delivery systems with multiple closure points pose challenges for container closure integrity testing.

Separation of Compliance and Performance Under FDASIA

March 2, 2014

Pharmaceutical Technology

The root cause of drug shortages is mismanagement of variation.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

The Survey is no longer available, please check later.
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here